Cefdinir
Alternative Names: BMY 28488; Cefzon; Cefzon Capsule; CI 983; FK 482; FR 80482; Omnicef; PD 134393Latest Information Update: 05 Nov 2023
At a glance
- Originator Astellas Pharma
- Developer AbbVie; Astellas Pharma; Bausch Health Companies; JE II Pharmaceutical
- Class Antibacterials; Cephalosporins; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Bacterial infections; Otitis media; Otorhinolaryngological infections; Pneumonia; Respiratory tract infections; Skin and soft tissue infections